Report cover image

U.S. Medical Plastics Market Size, Share, Trends, Industry Analysis Report By Polymer Type (Thermoplastics, Elastomers, Biodegradable Polymers, Others), By Application, By Manufacturing – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Aug 01, 2025
Length 129 Pages
SKU # PLRS20381556

Description

The U.S. medical plastics market size is expected to reach USD 22.06 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Medical Plastics Market Share, Size, Trends, Industry Analysis Report By Polymer Type (Thermoplastics, Elastomers, Biodegradable Polymers, Others), By Application, By Manufacturing; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Medical plastics are specialized polymers used in healthcare for their durability, biocompatibility, and sterilization resistance. They are essential in devices such as syringes, IV tubes, surgical instruments, implants, and packaging. A few types of medical plastics include polyethylene (PE), polypropylene (PP), polyvinyl chloride (PVC), and polycarbonate (PC). These materials are chosen for their non-toxicity, flexibility, and ability to withstand harsh sterilization methods like autoclaving or gamma radiation. Medical plastics improve patient safety by reducing infection risks and enabling single-use disposables. They also enhance precision in diagnostic tools and prosthetics. Innovations such as biodegradable plastics and antimicrobial coatings are advancing sustainability and performance.

The U.S. is a key country in medical plastics, driven by advanced healthcare infrastructure and stringent FDA regulations. American manufacturers produce high-performance plastics for surgical devices, drug delivery systems, and wearable medical tech. Key materials include silicone for implants, PVC for blood bags, and PTFE for catheters. The market is growing due to rising demand for minimally invasive surgeries and home healthcare devices. Major U.S. companies such as DowDuPont, Eastman Chemical, and Saint-Gobain innovate in biocompatible and recyclable plastics. Regulatory standards ensure safety, while R&D focuses on smart plastics with embedded sensors. The U.S. also emphasizes sustainability, with increasing use of recycled and bio-based polymers.

U.S. Medical Plastics Market Report Highlights

In terms of polymer type, the thermoplastics segment accounted for 71.34% of the U.S. medical plastics market share in 2024 due to their superior versatility, chemical resistance, and ease of processing.

The biodegradable polymers segment is projected to register a CAGR of 8.5% from 2025 to 2034 due to increasing focus on sustainability and regulatory pressures to reduce medical waste.

Based on application, the medical instruments & devices segment held 56.45% of the U.S. medical plastics market share in 2024 due to high demand for durable, lightweight, and biocompatible materials used in surgical instruments, catheters, prosthetics, and implantable devices.

The medical disposables segment is expected to register a CAGR of 7.4% from 2025 to 2034, owing to growing concerns around infection prevention and cost-effective patient care.

In terms of manufacturing, the extrusion tubing segment dominated the U.S. medical plastics market, holding 42.78% of revenue share in 2024 due to the increasing need for flexible, biocompatible tubing used in catheters, IV lines, and dialysis equipment.

The injection molding is estimated to record a CAGR of 7.0% from 2025 to 2034, owing to its ability to produce complex medical components at scale.

A few key market players include Arkema, BASF, Celanese Corporation, Covestro, Dow, DuPont, Eastman Chemical Company, Ensinger, Evonik Industries AG, Lubrizol, RTP Company, SABIC, Solvay, Spectrum Plastics Group, and Teknor Apex.

Polaris Market Research has segmented the market report on the basis of polymer type, application, and manufacturing:

By Polymer Type Outlook (Revenue, USD Billion, 2021–2034)

Thermoplastics

Polypropylene (PP)

Polyvinyl Chloride (PVC)

Polyethylene (PE)

Polycarbonate (PC)

Polyurethane

Acrylonitrile Butadiene Styrene (ABS)

Others

Elastomers

Biodegradable Polymers

Others

By Application Outlook (Revenue, USD Billion, 2021–2034)

Medical Instruments & Devices

Medical Disposables

Diagnostic Instruments & Tools

Others

By Manufacturing Outlook (Revenue, USD Billion, 2021–2034)

Extrusion Tubing

Injection Molding

Compression Molding

Others

Table of Contents

129 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. U.S. Medical Plastics Market Insights
4.1. U.S. Medical Plastics Market – Market Snapshot
4.2. U.S. Medical Plastics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Geriatric Population
4.2.1.2. Increasing Healthcare Spending
4.2.2. Restraints and Challenges
4.2.2.1. Stringent Regulatory Compliance
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Medical Plastics Market Trends
4.6. Value Chain Analysis
5. U.S. Medical Plastics Market, by Polymer Type
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Medical Plastics Market, by Polymer Type, 2020-2034 (USD Billion)
5.3. Thermoplastics
5.3.1. U.S. Medical Plastics Market, by Thermoplastics, by Region, 2020-2034 (USD Billion)
5.3.2. Polypropylene (PP)
5.3.2.1. U.S. Medical Plastics Market, by Polypropylene (PP), by Region, 2020-2034 (USD Billion)
5.3.3. Polyvinyl Chloride (PVC)
5.3.3.1. U.S. Medical Plastics Market, by Polyvinyl Chloride (PVC), by Region, 2020-2034 (USD Billion)
5.3.4. Polyethylene (PE)
5.3.4.1. U.S. Medical Plastics Market, by Polyethylene (PE), by Region, 2020-2034 (USD Billion)
5.3.5. Polycarbonate (PC)
5.3.5.1. U.S. Medical Plastics Market, by Polycarbonate (PC), by Region, 2020-2034 (USD Billion)
5.3.6. Polyurethane
5.3.6.1. U.S. Medical Plastics Market, by Polyurethane, by Region, 2020-2034 (USD Billion)
5.3.7. Acrylonitrile Butadiene Styrene (ABS)
5.3.7.1. U.S. Medical Plastics Market, by Acrylonitrile Butadiene Styrene (ABS), by Region, 2020-2034 (USD Billion)
5.3.8. Others
5.3.8.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
5.4. Elastomers
5.4.1. U.S. Medical Plastics Market, by Elastomers, by Region, 2020-2034 (USD Billion)
5.5. Biodegradable Polymers
5.5.1. U.S. Medical Plastics Market, by Biodegradable Polymers, by Region, 2020-2034 (USD Billion)
5.6. Others
5.6.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
6. U.S. Medical Plastics Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Medical Plastics Market, by Application, 2020-2034 (USD Billion)
6.3. Medical Instruments & Devices
6.3.1. U.S. Medical Plastics Market, by Medical Instruments & Devices, by Region, 2020-2034 (USD Billion)
6.4. Medical Disposables
6.4.1. U.S. Medical Plastics Market, by Medical Disposables, by Region, 2020-2034 (USD Billion)
6.5. Diagnostic Instruments & Tools
6.5.1. U.S. Medical Plastics Market, by Diagnostic Instruments & Tools, by Region, 2020-2034 (USD Billion)
6.6. Others
6.6.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
7. U.S. Medical Plastics Market, by Manufacturing
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Medical Plastics Market, by Manufacturing, 2020-2034 (USD Billion)
7.3. Extrusion Tubing
7.3.1. U.S. Medical Plastics Market, by Extrusion Tubing, by Region, 2020-2034 (USD Billion)
7.4. Injection Molding
7.4.1. U.S. Medical Plastics Market, by Injection Molding, by Region, 2020-2034 (USD Billion)
7.5. Compression Molding
7.5.1. U.S. Medical Plastics Market, by Compression Molding, by Region, 2020-2034 (USD Billion)
7.6. Others
7.6.1. U.S. Medical Plastics Market, by Others, by Region, 2020-2034 (USD Billion)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Arkema
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. BASF
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Celanese Corporation
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Covestro
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. Dow
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. DuPont
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Eastman Chemical Company
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. Ensinger
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. Evonik Industries AG
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Lubrizol
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. Solvay
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us